Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBS-104 in Acutely Sleep-Deprived Healthy Participants
NCT07848659Phase 1Recruiting
- Sponsor
- Harmony Biosciences
- Start
- Aug 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HBS-104 in sleep deprivation (4 arms), sponsored by Harmony Biosciences. Primary endpoints: Maintenance of Wakefulness Test Mean Sleep Latency, Karolinska Sleepiness Scale and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
HBS-104
03
Conditions
sleep deprivation
Beyond the preview
Go deeper on NCT07848659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848659.